Efficacy of Metacognitive Training in a Chilean Sample of People with Schizophrenia.
Rev Colomb Psiquiatr (Engl Ed)
; 51(4): 301-308, 2022.
Article
em En, Es
| MEDLINE
| ID: mdl-36369153
INTRODUCTION: Moritz et al.'s metacognitive training (MCT), a new development of cognitive therapy, is a manualised group training programme, designed to correct cognitive biases involved in the formation and maintenance of psychotic symptoms, especially delusions. We report on the efficacy of MCT in a Chilean sample of people with schizophrenia. METHODS: 50 outpatients from the Hospital Del Salvador in Valparaíso, Chile, were randomly assigned to the intervention group that received MCT or the control group that only received treatment as usual (TAU). Subjects were assessed at the beginning and end of the study with the Positive and Negative Syndrome Scale (PANSS), Cognitive Biases Questionnaire for Psychosis (CBQ-P) and Beck Cognitive Insight Scale (BCIS). RESULTS: Greater statistically significant improvements were recorded in the MCT group, both in symptoms and cognitive biases and in cognitive insight, than in the control group. When comparing both groups, significant results in favor of MCT were only observed in positive symptoms. CONCLUSIONS: The results of this study suggest MCT is superior to TAU in treating positive symptoms. It was not possible to demonstrate its superiority in improving cognitive biases and cognitive insight.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtornos Psicóticos
/
Esquizofrenia
/
Terapia Cognitivo-Comportamental
/
Metacognição
Limite:
Humans
País/Região como assunto:
America do sul
/
Chile
Idioma:
En
/
Es
Revista:
Rev Colomb Psiquiatr (Engl Ed)
Ano de publicação:
2022
Tipo de documento:
Article
País de publicação:
Espanha